Specialty pharmaceutical-generic companies that expanded pipelines through M&A and revenue through price increases are now facing scrutiny on the sustainability of the traditional model and looking toward more investment in R&D.
A consumer study prepared by PwC to investigate how behavioral, regulatory, and technological disruption are changing consumer's approaches to managing their health.
Understand what consumers value most when managing their health and how much additional responsibility they’re willing to take on to reduce the cost of their healthcare.
The Biggest Healthcare Trends of 2019 and What's to Come in 2020Health Catalyst
In our Healthcare Outlook for 2019 webinar, Stephen Grossbart, PhD, and Bobbi Brown, MBA, shared their predictions for the biggest trends of the year. Which predictions panned out and which didn’t? View this webinar as Stephen takes a look back at 2019 and makes his forecast for 2020.
So, what did happen in 2019? Following the 2018 midterm elections, we predicted a divided Congress would not pass policies to strengthen or weaken the Affordable Care Act (ACA). We were right. Meanwhile, Democratic presidential candidates debated the extent to which they would support Medicare for All. Insurance costs continued to rise, breaking $20,000 annually for families with employer-sponsored coverage, and CMS continued to support payment policies rewarding quality and interoperability as part of their payment policy.
Join Stephen as he looks in the rearview mirror at these important issues and how they impacted the healthcare industry in 2019 and then gazes into the crystal ball to predict the trends that will most impact healthcare in 2020. In this webinar, Stephen discusses the following topics and more:
• The continued focus on price transparency.
• Congress’ efforts to control prescription drug costs.
• Policies that may change the future of ACOs.
• What to expect going into the 2020 election year.
Healthcare Price Transparency: Three Opportunities for TransformationHealth Catalyst
Price transparency has been an ongoing challenge for health systems, and upcoming legislation requiring increased visibility around hospital pricing adds pressure. Meeting the new price transparency requirements means legal compliance, but providing procedure costs, different payment options, and the reasoning behind prices set patients up for an optimal experience, increasing their likelihood to return for future care.
With the right tools, such as robust pricing transparency technology and a defensible price strategy, health systems can use the new mandate to take advantage of three key opportunities:
Satisfy increasing patient interest in cost of care.
Earn patient trust—a short- and long-term imperative.
Create the optimal patient experience.
2021 Healthcare Trends: Embracing an Unpredictable FutureHealth Catalyst
We’re putting 2020 in the rearview mirror and gazing into the crystal ball to see what 2021 holds. Stephen Grossbart, PhD, and Dan Orenstein, JD, tackle the challenge of predicting what’s next for healthcare in 2021. Stephen and Dan discuss the trends and policies most impactful to the industry and attempt to answer the following questions on everyone’s mind.
- Healthcare technology—Where is it headed? What’s the next big thing?
- Care delivery—How will COVID-19 continue to impact healthcare systems, physicians, and patients? What changes will the industry make to prepare for future pandemics? What will happen with value-based care?
- The new Biden administration—What changes will it make that will impact healthcare? What will the Supreme Court/Congress do about the ACA?
The Latest Healthcare Financial Trends: What You Need to KnowHealth Catalyst
As 2017 comes to an end, two of our most experienced and capable people are assessing this year’s most prominent healthcare financial trends and using those clues to better read the tea leaves to predict which trends will impact 2018. Tasked with delivering ground breaking financial software products, Dorian DiNardo, Senior Vice President, Analytics, daily has her finger to the wind to sense how shifting trends are impacting market needs. She will join Bobbi Brown, Senior Vice President, Professional Services, who will lead the webinar conversation. Bobbi has several impressive decades of experience in financial leadership for some of the most storied organizations including Intermountain, Sutter Health and Kaiser Permanente. Among other trends that popup in the next few weeks, she will examine three of 2017’s most significant healthcare trends:
Transitions in payment models
Healthcare market disruptions from well-known companies as well as some not-so-familiar newcomers
Emerging importance of technical data skillsets
A consumer study prepared by PwC to investigate how behavioral, regulatory, and technological disruption are changing consumer's approaches to managing their health.
Understand what consumers value most when managing their health and how much additional responsibility they’re willing to take on to reduce the cost of their healthcare.
The Biggest Healthcare Trends of 2019 and What's to Come in 2020Health Catalyst
In our Healthcare Outlook for 2019 webinar, Stephen Grossbart, PhD, and Bobbi Brown, MBA, shared their predictions for the biggest trends of the year. Which predictions panned out and which didn’t? View this webinar as Stephen takes a look back at 2019 and makes his forecast for 2020.
So, what did happen in 2019? Following the 2018 midterm elections, we predicted a divided Congress would not pass policies to strengthen or weaken the Affordable Care Act (ACA). We were right. Meanwhile, Democratic presidential candidates debated the extent to which they would support Medicare for All. Insurance costs continued to rise, breaking $20,000 annually for families with employer-sponsored coverage, and CMS continued to support payment policies rewarding quality and interoperability as part of their payment policy.
Join Stephen as he looks in the rearview mirror at these important issues and how they impacted the healthcare industry in 2019 and then gazes into the crystal ball to predict the trends that will most impact healthcare in 2020. In this webinar, Stephen discusses the following topics and more:
• The continued focus on price transparency.
• Congress’ efforts to control prescription drug costs.
• Policies that may change the future of ACOs.
• What to expect going into the 2020 election year.
Healthcare Price Transparency: Three Opportunities for TransformationHealth Catalyst
Price transparency has been an ongoing challenge for health systems, and upcoming legislation requiring increased visibility around hospital pricing adds pressure. Meeting the new price transparency requirements means legal compliance, but providing procedure costs, different payment options, and the reasoning behind prices set patients up for an optimal experience, increasing their likelihood to return for future care.
With the right tools, such as robust pricing transparency technology and a defensible price strategy, health systems can use the new mandate to take advantage of three key opportunities:
Satisfy increasing patient interest in cost of care.
Earn patient trust—a short- and long-term imperative.
Create the optimal patient experience.
2021 Healthcare Trends: Embracing an Unpredictable FutureHealth Catalyst
We’re putting 2020 in the rearview mirror and gazing into the crystal ball to see what 2021 holds. Stephen Grossbart, PhD, and Dan Orenstein, JD, tackle the challenge of predicting what’s next for healthcare in 2021. Stephen and Dan discuss the trends and policies most impactful to the industry and attempt to answer the following questions on everyone’s mind.
- Healthcare technology—Where is it headed? What’s the next big thing?
- Care delivery—How will COVID-19 continue to impact healthcare systems, physicians, and patients? What changes will the industry make to prepare for future pandemics? What will happen with value-based care?
- The new Biden administration—What changes will it make that will impact healthcare? What will the Supreme Court/Congress do about the ACA?
The Latest Healthcare Financial Trends: What You Need to KnowHealth Catalyst
As 2017 comes to an end, two of our most experienced and capable people are assessing this year’s most prominent healthcare financial trends and using those clues to better read the tea leaves to predict which trends will impact 2018. Tasked with delivering ground breaking financial software products, Dorian DiNardo, Senior Vice President, Analytics, daily has her finger to the wind to sense how shifting trends are impacting market needs. She will join Bobbi Brown, Senior Vice President, Professional Services, who will lead the webinar conversation. Bobbi has several impressive decades of experience in financial leadership for some of the most storied organizations including Intermountain, Sutter Health and Kaiser Permanente. Among other trends that popup in the next few weeks, she will examine three of 2017’s most significant healthcare trends:
Transitions in payment models
Healthcare market disruptions from well-known companies as well as some not-so-familiar newcomers
Emerging importance of technical data skillsets
Continuity of Care Documents: Today’s Top Solution for Healthcare Interoperab...Health Catalyst
While healthcare waits for the expanded data interoperability that FHIR promises, the industry needs an immediate solution for accessing and using disparate data from across the continuum of care. With FHIR potentially several years away, continuity of care documents (CCDs) are the best option for acquiring the ambulatory clinical care data health systems need to close quality gaps today. Because organizations that rely only on claims data to drive quality improvement risk missing out on more that 80 percent of patient information, CCDs are the current must-have answer to interoperability for successful quality improvement.
Artificial Intelligence in Healthcare: A Change Management ProblemHealth Catalyst
The key to successfully leveraging artificial intelligence (AI) in healthcare rests not wholly in the technical aspects of predictive and prescriptive machines but also in change management within healthcare organizations. Better adoption and results with AI rely on a commitment to the challenge of change, the right tools, and a human-centered perspective.
To succeed in change management and get optimal value from predictive and prescriptive models, clinical and operational leaders must use three perspectives:
Functional: Does the model make sense?
Contextual: Does the model fit into the workflow?
Operational: What benefits and risks are traded?
mHealth Israel_Levi Shapiro_Israel Digital Health Overview Levi Shapiro
Overview of digital health investment sector, including investment, funding and exit trends in the US and Israel, as well as successful case studies of eHealth companies in the US and Israel
Survey Shows the Role of Technology in the Progress of Patient SafetyHealth Catalyst
A lack of effective technology is impeding the progress of patient safety, according to a 2018 survey of healthcare professionals. Even though most healthcare organizations claim safety as a priority, serious challenges remain to making a significant impact on patient safety outcomes.
Survey respondents said ineffective information technology and the related lack of real-time warnings for possible harm events were the top barriers to improving patient safety. They cited a number of key obstacles:
Lack of resources.
Organization structure.
Lack of reimbursement for safety measures.
Changes in patient population.
This survey of more than 400 healthcare professionals tackles a big question many hospital leaders are asking: Why aren’t we seeing improvements in patient safety despite our efforts?
A Healthcare Mergers Framework: How to Accelerate the BenefitsHealth Catalyst
Health system mergers can promise significant savings for participating organizations. Research, however, indicates as much as a tenfold gap between expectation and reality, with systems looking for a savings of 15 percent but more likely to realize savings around 1.5 percent.
Driving the merger expectation-reality disparity is a complex process that, without diligent preparation and strategy, makes it difficult for organizations to fully leverage cost synergies. With the right framework, however, health systems can achieve the process management, data sharing, and governance structure to align leadership, clinicians, and all stakeholders around merger goals.
New Global Healthcare Another Chapter In Healthcare Marketing Brand ManagementJGB1
Emerging healthcare markets are moving into new phases as access to care increases and clinical / payer administration becomes more established. Successful healthcare marketing ventures require a balanced clinical / cost value proposition based on each nation\'s specific healthcare delivery, government and payer model.
How to Run Your Healthcare Analytics Operation Like a BusinessHealth Catalyst
A robust data analytics operation is necessary for healthcare systems’ survival. Just like any business, the analytics enterprise needs to be well managed using the principles of successful business operations.
This article walks through how to run an analytics operation like a business using the following five-question framework:
Who does the analytics team serve and what are those customers trying to do?
What services does the analytics team provide to help customers accomplish their goals?
How does the analytics team know they’re doing a great job and how do they communicate that effectively to the leadership team?
What is the most efficient way to provide analytics services?
What is the most effective way to organize?
Mercer Capital's Value Focus: Medical Technology | Mid-Year 2021Mercer Capital
Mercer Capital's Medical Technology Industry newsletter provides perspective on valuation issues. Each newsletter also includes macroeconomic trends, public market trends, and comparable public company metrics.
Six Ways Health Systems Use Analytics to Improve Patient SafetyHealth Catalyst
With preventable patient harm associated with over 400,000 deaths in the U.S. annually, improving safety is a top priority for healthcare organizations. To reduce risks for hospitalized patients, health systems are using patient safety analytics and trigger-based surveillance tools to better understand and recognize the types of harm occurring at their facilities and intervene as early as possible.
Six examples of analytics-driven patient safety success cover improvement in the following areas:
Wrong-patient order errors.
Blood management.
Clostridioides difficile (C. diff).
Opioid dependence.
Event reporting.
Sepsis.
Accountable Care Organizations (ACOs) and clinically integrated networks (CINs) are two types of organizations working to address the problem of rising costs. As ACOs and CINs continue to evolve, organizations moving into value-based care (VBC) face an ever-changing landscape. This article looks at the evolution of the ACO and CIN models, what new tools ACOs employ today to promote success, and lessons learned from organizations that have succeeded in alternative payment models. It also explores what healthcare experts believe the future of alternative payment models will look like and competencies to develop to meet those changing demands.
Hospital Capacity Management: How to Prepare for COVID-19 Patient SurgesHealth Catalyst
Health system resource strain became an urgent concern early in the COVID-19 pandemic. Hard-hit areas exhausted their hospital beds, ventilators, personal protective equipment, staffing, and other life-saving essentials, while other regions scrambled to prepare for inevitable surges. These resource concerns heightened the need for accurate, localized hospital capacity planning. With additional waves of infection in the summer months following the initial spring 2020 crisis, health systems must continue to forecast resource demands for the foreseeable future. An accurate capacity planning tool uses population demographics, governmental policies, local culture, and the physical environment to predict healthcare resource needs and help health systems prepare for surges in patient demand.
ACOs and CINs — Where Did They Start, How Have They Evolved, and Where Are Th...Health Catalyst
As the types and structures of Accountable Care Organizations (ACOs) and Clinically Integrated Networks (CINs) continue to evolve, organizations moving into value-based care face an ever-changing landscape. Alternative payment model arrangements have driven provider organizations to hone in on specific tactics to meet their contractual and strategic objectives.
Please join Health Catalyst Senior Vice President Dr. Amy Flaster and Population Health Management Consultant Jonas Varnum as they discuss the evolution of the ACO and CIN models, what new tools ACOs employ today to promote success, and lessons learned from organizations that have succeeded in alternative payment models. They will dive deep into lessons learned in addition to providing a primer on what has always been and continues to be vitally important to success in value based care. Specifics they will cover include:
- Approaches to simplify quality metric reporting
- Enhanced methodology that zeroes in on identifying high-value opportunities to improve patient populations
- Key tips to expand your business with new contracts
Dr. Flaster and Mr. Varnum’s combined experience make them uniquely qualified to guide you in your ACO or CIN journey. Dr. Flaster comes from a clinical background where she worked as Associate Medical Director at Partners HealthCare - one of the largest ACOs in the country. Mr. Varnum is a professional services strategy leader with demonstrated expertise delivering payment model transformation and helping providers and payers to strategically adjust their operations.
Customer Journey Analytics: Cracking the Patient Engagement Challenge for PayersHealth Catalyst
Customer journey analytics uses machine learning and big data to track and analyze when and through what channels customers interact with an organization, with an aim to influence behavior (e.g., buying behaviors among retail customers). Similarly, healthcare organizations want to influence health-related behaviors, such a taking medication as prescribed and not smoking, to improve outcomes and lower the cost of care. In a partnership with an analytics services provider, a payer organization is leveraging customer journey analytics among healthcare consumers to identify the best opportunities and channels for patient outreach. With this analytics-driven engagement strategy, the payer has found an opportunity to significantly improve patient engagement—a predicted overall increase from 18 percent to 31 percent.
During the 2018 mid-term elections, candidates faced off making big claims that they would be the ones to fix healthcare. Now that they are back to work, what can we anticipate with a new Congress? Will we finally see improvements or gridlock? Join Bobbi Brown, MBA and Stephen Grossbart, PhD as they tackle these questions along with a 2018 lookback of what went right and 2019 predictions of the most important trends that will impact our daily work.
Beyond political maneuvering, in 2018 we saw material changes in the business of healthcare. The pace of mergers, acquisitions and partnerships was strong and deals like the pending acquisition of Aetna by CVS, could dramatically impact patient behavior and revenue streams. In addition, the Center for Medicare & Medicaid Services (CMS) continues to support existing programs while adding new measures to support transparency, interoperability and a continued shift to value-based payments. What does this mean for your organization in 2019? View this webinar to learn more across these areas:
- The business of healthcare including new market entrants, business models and shifting strategies to stay competitive.
- Continuous quality and cost control monitoring across populations.
- CMS proposals to push ACOs into two-sided risk models.
- Historic changes to Merit-based Incentive Payment System (MIPS).
- Fewer process measures but more quality outcomes scrutiny for providers.
- Increased consumer demand for more transparency.
There are many challenges and opportunities for all of us in healthcare. Join Bobbi and Stephen as they draw upon their decades of experience to make sense of the past year and look ahead to give you guidance for the new year. This is the fourth year running that Bobbi has presented her predictions at the turn of the new year and past attendees will remember that her knack for predicting is uncanny and her stories are unforgettable. This time was no different.
The base metals with the biggest price gains in 2016 have
been the ones that underwent sizable production cuts in 2015,
especially zinc. The tailwinds behind precious metals that supported prices in 2016 will only grow in 2017.
Learn about the healthcare IT trends that will shape 2017 and beyond. Discover how healthcare on the blockchain will move from theory to practice, how the Trump presidency will rock the healthcare boat, how demand will drive adoption of healthcare e-commerce and how telehealth will finally go mainstream.
Continuity of Care Documents: Today’s Top Solution for Healthcare Interoperab...Health Catalyst
While healthcare waits for the expanded data interoperability that FHIR promises, the industry needs an immediate solution for accessing and using disparate data from across the continuum of care. With FHIR potentially several years away, continuity of care documents (CCDs) are the best option for acquiring the ambulatory clinical care data health systems need to close quality gaps today. Because organizations that rely only on claims data to drive quality improvement risk missing out on more that 80 percent of patient information, CCDs are the current must-have answer to interoperability for successful quality improvement.
Artificial Intelligence in Healthcare: A Change Management ProblemHealth Catalyst
The key to successfully leveraging artificial intelligence (AI) in healthcare rests not wholly in the technical aspects of predictive and prescriptive machines but also in change management within healthcare organizations. Better adoption and results with AI rely on a commitment to the challenge of change, the right tools, and a human-centered perspective.
To succeed in change management and get optimal value from predictive and prescriptive models, clinical and operational leaders must use three perspectives:
Functional: Does the model make sense?
Contextual: Does the model fit into the workflow?
Operational: What benefits and risks are traded?
mHealth Israel_Levi Shapiro_Israel Digital Health Overview Levi Shapiro
Overview of digital health investment sector, including investment, funding and exit trends in the US and Israel, as well as successful case studies of eHealth companies in the US and Israel
Survey Shows the Role of Technology in the Progress of Patient SafetyHealth Catalyst
A lack of effective technology is impeding the progress of patient safety, according to a 2018 survey of healthcare professionals. Even though most healthcare organizations claim safety as a priority, serious challenges remain to making a significant impact on patient safety outcomes.
Survey respondents said ineffective information technology and the related lack of real-time warnings for possible harm events were the top barriers to improving patient safety. They cited a number of key obstacles:
Lack of resources.
Organization structure.
Lack of reimbursement for safety measures.
Changes in patient population.
This survey of more than 400 healthcare professionals tackles a big question many hospital leaders are asking: Why aren’t we seeing improvements in patient safety despite our efforts?
A Healthcare Mergers Framework: How to Accelerate the BenefitsHealth Catalyst
Health system mergers can promise significant savings for participating organizations. Research, however, indicates as much as a tenfold gap between expectation and reality, with systems looking for a savings of 15 percent but more likely to realize savings around 1.5 percent.
Driving the merger expectation-reality disparity is a complex process that, without diligent preparation and strategy, makes it difficult for organizations to fully leverage cost synergies. With the right framework, however, health systems can achieve the process management, data sharing, and governance structure to align leadership, clinicians, and all stakeholders around merger goals.
New Global Healthcare Another Chapter In Healthcare Marketing Brand ManagementJGB1
Emerging healthcare markets are moving into new phases as access to care increases and clinical / payer administration becomes more established. Successful healthcare marketing ventures require a balanced clinical / cost value proposition based on each nation\'s specific healthcare delivery, government and payer model.
How to Run Your Healthcare Analytics Operation Like a BusinessHealth Catalyst
A robust data analytics operation is necessary for healthcare systems’ survival. Just like any business, the analytics enterprise needs to be well managed using the principles of successful business operations.
This article walks through how to run an analytics operation like a business using the following five-question framework:
Who does the analytics team serve and what are those customers trying to do?
What services does the analytics team provide to help customers accomplish their goals?
How does the analytics team know they’re doing a great job and how do they communicate that effectively to the leadership team?
What is the most efficient way to provide analytics services?
What is the most effective way to organize?
Mercer Capital's Value Focus: Medical Technology | Mid-Year 2021Mercer Capital
Mercer Capital's Medical Technology Industry newsletter provides perspective on valuation issues. Each newsletter also includes macroeconomic trends, public market trends, and comparable public company metrics.
Six Ways Health Systems Use Analytics to Improve Patient SafetyHealth Catalyst
With preventable patient harm associated with over 400,000 deaths in the U.S. annually, improving safety is a top priority for healthcare organizations. To reduce risks for hospitalized patients, health systems are using patient safety analytics and trigger-based surveillance tools to better understand and recognize the types of harm occurring at their facilities and intervene as early as possible.
Six examples of analytics-driven patient safety success cover improvement in the following areas:
Wrong-patient order errors.
Blood management.
Clostridioides difficile (C. diff).
Opioid dependence.
Event reporting.
Sepsis.
Accountable Care Organizations (ACOs) and clinically integrated networks (CINs) are two types of organizations working to address the problem of rising costs. As ACOs and CINs continue to evolve, organizations moving into value-based care (VBC) face an ever-changing landscape. This article looks at the evolution of the ACO and CIN models, what new tools ACOs employ today to promote success, and lessons learned from organizations that have succeeded in alternative payment models. It also explores what healthcare experts believe the future of alternative payment models will look like and competencies to develop to meet those changing demands.
Hospital Capacity Management: How to Prepare for COVID-19 Patient SurgesHealth Catalyst
Health system resource strain became an urgent concern early in the COVID-19 pandemic. Hard-hit areas exhausted their hospital beds, ventilators, personal protective equipment, staffing, and other life-saving essentials, while other regions scrambled to prepare for inevitable surges. These resource concerns heightened the need for accurate, localized hospital capacity planning. With additional waves of infection in the summer months following the initial spring 2020 crisis, health systems must continue to forecast resource demands for the foreseeable future. An accurate capacity planning tool uses population demographics, governmental policies, local culture, and the physical environment to predict healthcare resource needs and help health systems prepare for surges in patient demand.
ACOs and CINs — Where Did They Start, How Have They Evolved, and Where Are Th...Health Catalyst
As the types and structures of Accountable Care Organizations (ACOs) and Clinically Integrated Networks (CINs) continue to evolve, organizations moving into value-based care face an ever-changing landscape. Alternative payment model arrangements have driven provider organizations to hone in on specific tactics to meet their contractual and strategic objectives.
Please join Health Catalyst Senior Vice President Dr. Amy Flaster and Population Health Management Consultant Jonas Varnum as they discuss the evolution of the ACO and CIN models, what new tools ACOs employ today to promote success, and lessons learned from organizations that have succeeded in alternative payment models. They will dive deep into lessons learned in addition to providing a primer on what has always been and continues to be vitally important to success in value based care. Specifics they will cover include:
- Approaches to simplify quality metric reporting
- Enhanced methodology that zeroes in on identifying high-value opportunities to improve patient populations
- Key tips to expand your business with new contracts
Dr. Flaster and Mr. Varnum’s combined experience make them uniquely qualified to guide you in your ACO or CIN journey. Dr. Flaster comes from a clinical background where she worked as Associate Medical Director at Partners HealthCare - one of the largest ACOs in the country. Mr. Varnum is a professional services strategy leader with demonstrated expertise delivering payment model transformation and helping providers and payers to strategically adjust their operations.
Customer Journey Analytics: Cracking the Patient Engagement Challenge for PayersHealth Catalyst
Customer journey analytics uses machine learning and big data to track and analyze when and through what channels customers interact with an organization, with an aim to influence behavior (e.g., buying behaviors among retail customers). Similarly, healthcare organizations want to influence health-related behaviors, such a taking medication as prescribed and not smoking, to improve outcomes and lower the cost of care. In a partnership with an analytics services provider, a payer organization is leveraging customer journey analytics among healthcare consumers to identify the best opportunities and channels for patient outreach. With this analytics-driven engagement strategy, the payer has found an opportunity to significantly improve patient engagement—a predicted overall increase from 18 percent to 31 percent.
During the 2018 mid-term elections, candidates faced off making big claims that they would be the ones to fix healthcare. Now that they are back to work, what can we anticipate with a new Congress? Will we finally see improvements or gridlock? Join Bobbi Brown, MBA and Stephen Grossbart, PhD as they tackle these questions along with a 2018 lookback of what went right and 2019 predictions of the most important trends that will impact our daily work.
Beyond political maneuvering, in 2018 we saw material changes in the business of healthcare. The pace of mergers, acquisitions and partnerships was strong and deals like the pending acquisition of Aetna by CVS, could dramatically impact patient behavior and revenue streams. In addition, the Center for Medicare & Medicaid Services (CMS) continues to support existing programs while adding new measures to support transparency, interoperability and a continued shift to value-based payments. What does this mean for your organization in 2019? View this webinar to learn more across these areas:
- The business of healthcare including new market entrants, business models and shifting strategies to stay competitive.
- Continuous quality and cost control monitoring across populations.
- CMS proposals to push ACOs into two-sided risk models.
- Historic changes to Merit-based Incentive Payment System (MIPS).
- Fewer process measures but more quality outcomes scrutiny for providers.
- Increased consumer demand for more transparency.
There are many challenges and opportunities for all of us in healthcare. Join Bobbi and Stephen as they draw upon their decades of experience to make sense of the past year and look ahead to give you guidance for the new year. This is the fourth year running that Bobbi has presented her predictions at the turn of the new year and past attendees will remember that her knack for predicting is uncanny and her stories are unforgettable. This time was no different.
The base metals with the biggest price gains in 2016 have
been the ones that underwent sizable production cuts in 2015,
especially zinc. The tailwinds behind precious metals that supported prices in 2016 will only grow in 2017.
Learn about the healthcare IT trends that will shape 2017 and beyond. Discover how healthcare on the blockchain will move from theory to practice, how the Trump presidency will rock the healthcare boat, how demand will drive adoption of healthcare e-commerce and how telehealth will finally go mainstream.
2017 Healthcare Trends. A look into the Top 5 Healthcare Trends for 2017 from www.klara.com. Manage your healthcare practice operations efficiently and prepare for the future with this analysis of the top healthcare trends predicted for 2017. Technology is a key theme in this report.
Election results in the U.S. and U.K., and 2017 elections in several European countries, may fuel more of an inward focus, tamping down aggressive climate-change goals and other environmental, social and governance (ESG) efforts.
Top Health Care Regulatory Trends: New Risks and OpportunitiesEpstein Becker Green
From Epstein Becker Green and EBG Advisors: Policy & Legal Trends Impacting Health Care Investment - for more information, please visit http://www.ebglaw.com/PEdownloads
Chains that embrace technology fare best in restaurant warsBloomberg LP
Domino’s, Starbucks and Taco Bell are embracing technology
to gain market share over rival restaurant chains that have
been slower to adapt and independents that can’t afford to.
From Epstein Becker Green and EBG Advisors: Policy & Legal Trends Impacting Health Care Investment - for more information, please visit http://www.ebglaw.com/PEdownloads
If your company is public, Bloomberg monitors its environmental, social, and governance (ESG) performance – even if your company does not issue a sustainability report. Working with published data and news items, Bloomberg researchers crunch thousands of companies’ ESG disclosure performance into one number: a disclosure score.
To find out your company’s disclosure score, contact Sun:
https://www.linkedin.com/in/mcelderry
This originally appeared at http://framework-llc.com/bloomberg-esg-disclosure-scores-behind-the-terminal/
How Boston is becoming the best place in the world for BigCo/startup/academic...Scott Kirsner
Presentation I gave November 18th at the MassTLC's Transform conference, focusing on the Boston area's advantages for large companies seeking to collaborate with startups and academic researchers.
The World Economic Forums Annual Report published 7th Sept 2016. "Our World is an interconnected system, straining under the burden of its own complexity.... " Klaus Schwab. (Founder and Exec Chairman. What do you think?
Bloomberg Intelligence: US Healthcare Outlook 2015Bloomberg LP
Entering 2015, impacts of the Affordable Care Act will continue to shape the healthcare landscape for both patients and providers. The industry may also see new product launches from medical device companies looking to offset stagnant sales.
As pharmaceutical manufacturers look for ways to build
stronger relationships with their Integrated Delivery Network
(IDN) clients, RWE is emerging as a desired infrastructure
capability, presenting a window of opportunity to support and
collaborate on IDN efforts. If done well, these RWE-related
partnerships should provide value for both parties involved
but require pharma to expand its mindset beyond
product-specific approaches.
Identifying & Overcoming Gaps in the Specialty-Pharmacy EcosystemCognizant
Specialty drug expenditures in the U.S. are rising dramatically, compelling manufacturers to accelerate the turnaround time from patient enrollment to drug disbursement. Using data analytics tools, these companies can track patients throughout their treatment and ensure continuous patient therapy.
How is drug spending affected in the year 2017Steve Martin
As per the reports published in American Journal of Health-System Pharmacy (AJHP) in the year 2016, national trends in prescription drug expenditures were projected to increase by 6 to 8% in 2017 across all healthcare settings.
What Can Private Equity Do for Home Healthcare?Matthew Doyle
In recent years, private equity firms have risen to the forefront of the conversation around healthcare innovation and, in the process, firmly established themselves as drivers for change.
US Healthcare Reform Landscape - Addendum to June 2018 Presentation to the Ch...Dan Wellisch
This is an addendum to the June 2018 presentation (to the Chicago Technology For Value-Based Healthcare Meetup https://www.meetup.com/Chicago-Technology-For-Value-Based-Healthcare-Meetup/) containing interesting info. about what may replace the Affordable Care Act
Healthcare reform: Five trends to watch as the Affordable Care Act turns fivePwC
In its first five years, the Affordable Care Act (ACA) has had a profound, and likely irreversible, impact on the business of healthcare. Industry leaders must rethink strategies to remain relevant in a post-ACA world.
Web Page: http://www.pwc.com/us/acahealthreform
Rising prevalence of breast cancer pertaining to factors such as prolonged exposure to endogenous oestrogens, early menarche, late age at first childbirth and late menopause will be a high impact rendering factor for the industry growth. Increasing technological advances in cancer biology and launch of several diagnostic and screening programs worldwide should drive the business size. Growing adoption of therapeutics owing to factors such as blocking estrogenic from binding to tumour cells, risk of distant reappearance, lowering jeopardy of reappearance in the breast that had tumour and reducing risk of developing disease in another breast will propel the industry growth.
Growing awareness regarding breast cancer, rising shift towards adoption of western lifestyle, short breast-feeding timeframe and rising prevalence of obesity in women after menopause will drive the industry size. Increasing rate of alcohol consumption in women, rising use of hormone replacement therapy (HRT) and oral birth control pills resulting in increased levels of oestrogen will boost the business size over the forecast period. Growing exposure to certain carcinogens and endocrine disruptors, for example in the workplace, working night shifts results in increased risk are surging up the U.S. market
Prohibitive cost associated with the use of breast cancer therapeutics may hamper the industry growth. Increasing cost of early and late-stage disease therapy, continuing care on a per-unit time basis, accounting for the major share of lifetime cost owing to relatively extended survival of breast cancer patients may further restrain the business growth
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us at info@insights10.com
THE BIDEN PLAN TO PROTECT & BUILD ON THE AFFORDABLE CARE ACTDr Matthew Boente MD
From the time right before the Affordable Care Act’s key coverage-related policies went into effect to the last full year of the Obama-Biden Administration, 2016, the number of Americans lacking health insurance fell from 44 million to 27 million – an almost 40% drop. But President Trump’s persistent efforts to sabotage Obamacare through executive action, after failing in his efforts to repeal it through Congress, have started to reverse this progress. Since 2016, the number of uninsured Americans has increased by roughly 1.4 million
Presentation by Michael Cohen, an analyst in CBO’s Health Analysis Division, and Tamara Hayford, Chief of CBO’s Health Policy Studies Unit, at the Congressional Research Service.
The Top Three 2020 Healthcare Trends and How to PrepareHealth Catalyst
After a tumultuous 2019, healthcare organizations are pivoting to make sense of the latest changes and prepare to face the top 2020 healthcare trends:
Consumerism—Can health systems respond to the consumer demands of better access and price transparency?
Financial Performance—With mergers, acquisitions, and private sector companies entering the healthcare arena, how will traditional hospitals and clinics compete?
Social Issues—How will health organizations respond to the opioid crisis and consider social determinants of health as part of the care process to provide comprehensive treatment?
As health systems struggle to survive amidst constant change, they must look forward and proactively prepare for what’s to come in 2020.
A new report from PwC’s Health Research Institute predicts that insurance companies will be spending more to pay for prescription drugs starting next year, from around 3% to almost 6% by 2027. Here’s more forecasts on medical spending from the report:
•Generics: Almost half of the estimated sales from the top 100 brand-name drugs won’t be affected by generic competition for another three years.
•Specialty drugs: Spending on specialty drugs — such as biologics or rare disease treatments — has already been growing over the past five years, but by 2020 these drugs may make up more than half of all U.S. drug spending.
•Chronic disease: 85% of all employer-provided insurance spending is on chronic conditions, and obesity and diabetes will be the two top conditions that will account for spending in 2020.
Asia's major economies, China and Japan, are poised for a year of slowing growth and central bank transitions. Elsewhere in the region, the outlook is more mixed and in most of ASEAN, tepid private demand will keep rate hikes off the table.
Asia will power the next stage of environmental, social and
governance (ESG) uptake in 2018 as China is poised to join Japan
in accelerating disclosure and engagement. China’s pollution
battle will keep the heat on fighting carbon emissions globally,
even as the U.S. disengages.
Channel checks in China’s metal marketsBloomberg LP
Rising supply of late-cycle commodities, including copper and
aluminum, together with uncertain Chinese demand may continue to weigh on metal prices this year.
2016 Election: Who will win the TV ad races?Bloomberg LP
While political TV ad forecasts vary, 2016 may set a record. Experts agree that this will be the biggest year for political ads on TV, even with $1 billion in estimated digital spending.
Global cable & satellite: 2016 outlookBloomberg LP
M&A continues to be a key theme across the U.S. pay-TV market. European pay-TV operators proved their resilience amid rising competition in 2015 as industry video losses were contained and the slowdown in broadband net additions was limited.
OPEC oil output will likely remain elevated in 2016 as U.S. volumes decline modestly, even with large cuts in capital spending and rigs. Refined product demand may increase 1% in 2016, after growth of about 3% in 2015 as low oil prices continue to stimulate demand and outrun efficiencies.
Global consumer discretionary: 2016 outlookBloomberg LP
Apparel retailers cannot ignore online shopping as the transition from stores accelerates and mobile browsing becomes the starting point for many purchases.
Production rates, revenue and profit pose little risk to the
aerospace industry in 2016 as backlogs are full. Rather,
planemakers ponder the risk and reward of spending money to
raise future production rates.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
1. Global healthcare 2017 outlook
Elizabeth Krutoholow, Curt Wanek, Brian Rye, Jason McGorman,
Ian Person, Sam Fazeli, Michael Shah
Bloomberg Intelligence analysts
3. The rapid pace of innovation among drugmakers may continue
to be overshadowed by broader investment themes, such as the
switch away from defensive stocks into more cyclical industries,
during 2017.
Though Donald Trump’s election victory means government
price controls are much less likely, payor pressure on drug
pricing continues. With cash remaining cheap, particularly if U.S.
companies can repatriate their hoards at a low tax rate, smaller
drugmakers may find themselves targeted by pipeline-hungry
large pharma.
5. Large pharma may remain mostly focused on smaller deals in
2017, according to company management teams. Bids for Anacor
(Pfizer), Stemcentrx (AbbVie), Medivation (Sanofi) and Actelion
(Johnson & Johnson) underscore the fact that biotech valuations,
which are significantly below previous highs, are opening the door
to discussions.
Access to cheap cash is a significant driver, as will be repatriated
cash for U.S. large pharma. The U.K.’s decision to leave the EU may
prolong the period of relaxed monetary policy.
7. With the Republicans taking all key political power positions in the
U.S., drug companies may have escaped the brunt of potential
government drug-pricing control, while their tax burden could
ease as parts of Obamacare are repealed.
One risk of negative headline news in 2017 is other states, notably
Ohio, having a measure like that defeated in California on the
ballot in 2017. California’s Proposition 61 was aimed at preventing
state agencies from paying more than the U.S. Department of
Veterans Affairs for drugs.
9. Specialty pharmaceutical-generic companies that expanded
pipelines through M&A and revenue through price increases are
now facing scrutiny on the sustainability of the traditional model
and looking toward more investment in R&D. Price pressures
that contributed to the 36% sector decline in 2016 may abate
somewhat in 2017 under President-elect Donald Trump. While
price probes are likely to continue, limited action by Congress
may not hinder moderate price increases on the magnitude of
10% a year.
Companies that continue to reinvest in their pipelines and show
organic growth in addition to expansion through M&A are likely to
continue to succeed.
11. Prices of specialty pharmaceuticals are still likely to rise about
9-10% a year, despite payer pressure and congressional probes on
specialty pharma tactics, which are only likely to deter aggressive
increases such as those historically employed by Valeant.
Methods for the government to regulate cost remain
prohibited but rebating may be a viable way to temper high list
prices. Generic-drug prices are in a deflationary period after
consolidation among distributors and a boost in FDA approvals.
13. Specialty pharmaceutical suitors have been attracted by the rich drug
pipelines with relatively limited competition and quick avenues to
regulatory approval. Medicines targeting chronic diseases provide
valuable long-term growth, but a wave of mergers has left fewer
targets available.
Still, specialty pharma’s potentially lucrative model will likely lead to
further consolidation in the sector. Allergan, itself a possible target
since the Pfizer deal is off the table, will make bolt-on acquisitions
15. Health insurers may be poised for stronger revenue and EPS
growth if Republicans strengthen Medicare Advantage and repeal
some of the Obamacare taxes, but Medicaid providers risk losing
some earnings. The public exchanges may still be a headwind
for remaining insurers such as Anthem in 2017 as few additional
enrollees are expected to sign up.
Court rulings for the major M&A deals for Aetna and Anthem may
be released in early 1Q, which could cause a domino effect as peers
deploy capital to respond.
17. President-elect Donald Trump and Republicans may repeal parts of
Obamacare, which could ease losses for health insurers near-term
but cut earnings in the long run. The insurer tax delay may boost
EPS for payers in 2017, mostly for Humana, and would be a positive if
repealed entirely.
Public exchange premiums are set to rise 25% on average, which
should help stem losses. Anthem may be the most exposed payer to
Obamacare plans in 2017 and could pick up costly members as peers
scale back.
19. UnitedHealth and Aetna may lead Medicare Advantage growth
among publicly traded health insurers, given they have the highest-
rated plan offerings. Enrollment growth may slow for Humana and
Cigna as plan ratings were cut.
Cigna isn’t allowed to market plans, given the government levied
sanctions because Cigna denied patients access to care and certain
drugs. Medicare Advantage enrollment may grow at a high-single-
digit pace through 2019 due to an aging population, among the
fastest-growing in health insurance.
21. Aetna and Anthem could gain significant scale and pricing power
if they were able to close pending acquisitions in 1H. Aetna may
have a clearer path to a settlement with the Justice Department
because Medicare Advantage is a local product rather than
national, but its divestiture plan may not yet be satisfactory.
Anthem’s purchase of Cigna is more challenging, given the
Justice Department is alleging harm to competition for the
national account market.
22. Bloomberg Intelligence offers valuable insight and company data,
interactive charting and written analysis with government, credit
insights from a team of independent experts, giving trading and
investment professionals deep insight into where crucial industries
start today and where they may be heading next.